skip to content
Cancer Prevention Fellowship Program
Evaluation of the NCIís Cancer Prevention Fellowship Program (CPFP): Final Report

Cover of Evaluation of the NCIís Cancer Prevention Fellowship Program (CPFP): Final ReportDownload the report
(PDF 1.54MB)

Alumni Spotlight

The Cancer Prevention Fellowship Program (CPFP) is proud of its many accomplished alumni. Their education and experience helped to prepare them for successful pursuits in many cancer prevention fields. We are pleased to spotlight a few of our outstanding alumni and their accomplishments.

Paul Limburg, MD, MPH

CPFP Fellow, 1998-2000

Photo of Paul Limburg, MD, MPH

Paul Limburg, MD, MPH, is a gastroenterologist and professor of medicine in the College of Medicine at the Mayo Clinic. He is also a consultant in the Department of Gastroenterology and Hepatology and the medical director of the Preventive Services Clinic in the Division of Preventive, Occupational, and Aerospace Medicine also at the Mayo Clinic. Dr. Limburg and colleagues completed the largest prospective investigation reported to date of CT colonography as a primary colorectal cancer screening option. He is also the principal investigator for the Cancer Prevention Network (CPN), a cancer clinical trials consortium. Through the CPN, Dr. Limburg organized and activated numerous prospective trials for colorectal, esophageal, lung, and multi-organ cancer chemoprevention, including the first-ever "phase 0" trial in preventive oncology. Dr. Limburg has served on numerous NCI study sections.

Sharon Glynn, PhD, MPH

CPFP Fellow, 2005-2009

Photo of Sharon Glynn, PhD, MPH

A graduate of our Ireland-Northern Ireland-NCI Cancer Consortium, Sharon Glynn, PhD, MPH left the NCI in fall 2010 to become the Director of Laboratory Research at the Prostate Cancer Institute at the National University of Ireland in Galway, Ireland. On April 1, 2011 Dr. Glynn was joined by the President of Ireland, Mary McAleese, to launch the Prostate Cancer Institute. Dr. Glynn was also recently featured in The Irish Times (story 4) for International Women's Day as a woman making a difference. Dr. Glynn's research program at NCI focused on the impact of estrogen receptor (ER) status in breast cancer, the role of inflammation, and subsequent prognosis.

Neal D. Freedman, PhD, MPH

CPFP Fellow, 2004-2008

Neal D. Freedman, PhD, MPH, is a Tenure-Track Investigator in the Nutritional Epidemiology Branch of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. He graduated from Brown University with a Bachelor of Science degree in biochemistry and history in 1998. Dr. Freedman then received a PhD in biomedical sciences from the University of California, San Francisco in 2004. As a Cancer Prevention Fellow, he joined the Nutritional Epidemiology Branch in 2005 in order to work with Drs. Christian Abnet and Sanford Dawsey on the etiology and early detection of esophageal cancer. Since that time, along with promotions to Research Fellow in 2008 and Tenure-Track investigator in 2009, his research interests have broadened to focus on cancers of the alimentary tract in three key areas: (1) diet and energy balance, (2) gastrointestinal conditions and hormones, and (3) tobacco and tobacco products. Recently, Dr. Freedman has become quite interested in findings linking coffee to lower risk of liver disease, liver cancer, and total and cause-specific mortality; and also how changes in the tobacco epidemic over time affect cancer and disease risk.

Philip Castle, PhD, MPH

CPFP Fellow, 2000-2003

Photo of Philip Castle, PhD, MPH

On January 1, 2011, Philip Castle, PhD, MPH became the first Executive Director of the American Society of Clinical Pathology (ASCP) Institute. Dr. Castle's professional interests are (1) epidemiology of human papillomaviruses (HPV) and cervical/anogenital cancer; (2) science and translation of cancer prevention strategies; (3) evidence-based medicine; and (4) international health. Dr. Castle has published over 200 papers on HPV and cervical cancer in medical journals; including articles in New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute, British Medical Journal, and Cancer Research. He currently serves on the editorial boards of the Journal of Infectious Diseases and Journal of Lower Genital Tract Disease. In 2006, Dr. Castle received the EUROGIN Distinguished Service Award and in 2007 the NIH Merit Award for his leadership in guiding the translation of human papillomavirus testing into cervical cancer screening for low-resource regions of the United States, and in 2010 he was awarded the highest honor of the ASCP, the Distinguished Scientific Achievement Award.

Top of Page

Deadline Alerts

Summer Curriculum

Registration to the CPFP Summer Curriculum is currently CLOSED.

If you would like to register for classes in 2018, please return in November 2017.

There is NO COST to register or attend either course.

Last modified: 08/02/2016

NIHÖTurning Discovery Into Health®